Patent Assignment
Reel/Frame 057708/0209
Assignment of Assignor's Interest
Recorded: 2021-10-05
Pages: 6
Assignors
CHAURET, NATHALIE
Executed: 2020-07-01
GARCEAU, DENIS
Executed: 2020-07-01
PAYZA, KEMAL
Executed: 2020-06-01
WENSLOW, ROBERT M., JR.
Executed: 2020-01-07
Assignee
BELLUS HEALTH COUGH INC.
275 ARMAND-FRAPPIER BLVD., LAVAL,QUEBEC, H7V 4A7, CANADA
Covered Property
(1)
Crystalline Forms of a Substituted Imidazopyridine Compound and Use Thereof as P2X3 Modulator
Application:
17/292,663 →
Publication:
US 2022/0002292
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Aug 9, 2023
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 064531/0830 →
Assignment of Assignor's Interest
Aug 9, 2023
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 065117/0909 →
Assignment of Assignor's Interest
Jan 19, 2024
From: 14245563 CANADA INC.
To: ID BIOMEDICAL CORPORATION OF QUEBEC
Reel/Frame 066353/0331 →
Assignment of Assignor's Interest
Jan 19, 2024
From: ID BIOMEDICAL CORPORATION OF QUEBEC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 066353/0356 →
Change of Address
Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 071351/0192 →